

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.16191002 |
| 2 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.02522545 |
| 3 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.90064526 |
| 4 | positive regulation of heat generation (GO:0031652) | 5.66940914 |
| 5 | regulation of fever generation (GO:0031620) | 5.66272537 |
| 6 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.38069497 |
| 7 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 5.28626068 |
| 8 | regulation of chemokine biosynthetic process (GO:0045073) | 5.26113994 |
| 9 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.21976514 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.04162172 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.04162172 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.04162172 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 5.04162172 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 5.04162172 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.04162172 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.77291092 |
| 17 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.73541817 |
| 18 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.55496099 |
| 19 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.53364636 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.38218360 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.32531561 |
| 22 | regulation of heat generation (GO:0031650) | 4.30917760 |
| 23 | superoxide anion generation (GO:0042554) | 4.30330891 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 4.24294001 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.24023840 |
| 26 | cellular response to exogenous dsRNA (GO:0071360) | 4.23322387 |
| 27 | reactive oxygen species biosynthetic process (GO:1903409) | 4.18466418 |
| 28 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.17666004 |
| 29 | positive regulation of prostaglandin secretion (GO:0032308) | 4.15030344 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 4.13257259 |
| 31 | regulation of prostaglandin secretion (GO:0032306) | 4.12480147 |
| 32 | negative regulation of interleukin-17 production (GO:0032700) | 4.09754973 |
| 33 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.09665901 |
| 34 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.09116125 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.08873512 |
| 36 | cellular response to nicotine (GO:0071316) | 4.05086646 |
| 37 | granulocyte activation (GO:0036230) | 4.03442382 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 4.01887901 |
| 39 | cellular response to interferon-beta (GO:0035458) | 4.01122745 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.99111010 |
| 41 | * regulation of vascular endothelial growth factor production (GO:0010574) | 3.93649268 |
| 42 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.91239914 |
| 43 | respiratory burst (GO:0045730) | 3.90578709 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.90353413 |
| 45 | leukocyte aggregation (GO:0070486) | 3.82436350 |
| 46 | eosinophil chemotaxis (GO:0048245) | 3.81354495 |
| 47 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.80224749 |
| 48 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.79651968 |
| 49 | negative regulation of lipid storage (GO:0010888) | 3.78305527 |
| 50 | regulation of histone phosphorylation (GO:0033127) | 3.73733515 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.69349421 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.67227546 |
| 53 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.66390901 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.65722470 |
| 55 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.65722470 |
| 56 | negative regulation by host of viral transcription (GO:0043922) | 3.62925882 |
| 57 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.61792146 |
| 58 | cellular response to lipopolysaccharide (GO:0071222) | 3.55355668 |
| 59 | negative regulation of viral genome replication (GO:0045071) | 3.53858013 |
| 60 | positive regulation of lymphocyte migration (GO:2000403) | 3.53693686 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.53052837 |
| 62 | regulation of interleukin-17 production (GO:0032660) | 3.52026085 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 3.49610041 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.48243314 |
| 65 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.47876437 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 3.47708014 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.47262419 |
| 68 | positive regulation of chemokine production (GO:0032722) | 3.44983923 |
| 69 | negative regulation of glucose transport (GO:0010829) | 3.42720908 |
| 70 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.42694336 |
| 71 | response to protozoan (GO:0001562) | 3.41365787 |
| 72 | eosinophil migration (GO:0072677) | 3.40654094 |
| 73 | cellular response to molecule of bacterial origin (GO:0071219) | 3.40187628 |
| 74 | * positive regulation vascular endothelial growth factor production (GO:0010575) | 3.39438937 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39217934 |
| 76 | response to host immune response (GO:0052572) | 3.39217934 |
| 77 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.39051152 |
| 78 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.38515880 |
| 79 | response to interferon-beta (GO:0035456) | 3.36253473 |
| 80 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.36045902 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35017613 |
| 82 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.34936335 |
| 83 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32880532 |
| 84 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.32092520 |
| 85 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.32092520 |
| 86 | regulation of mononuclear cell migration (GO:0071675) | 3.31679771 |
| 87 | monocyte chemotaxis (GO:0002548) | 3.31576067 |
| 88 | neutrophil activation (GO:0042119) | 3.30657108 |
| 89 | negative regulation of amino acid transport (GO:0051956) | 3.29714114 |
| 90 | T-helper 1 type immune response (GO:0042088) | 3.29661683 |
| 91 | regulation of podosome assembly (GO:0071801) | 3.28749536 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 3.25946928 |
| 93 | regulation of chronic inflammatory response (GO:0002676) | 3.25851521 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 3.24816073 |
| 95 | positive regulation of interleukin-6 production (GO:0032755) | 3.22439927 |
| 96 | microglial cell activation (GO:0001774) | 3.22369514 |
| 97 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21858994 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 3.19889009 |
| 99 | lymphocyte chemotaxis (GO:0048247) | 3.19510728 |
| 100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.19443813 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.19299311 |
| 102 | positive regulation of interleukin-12 production (GO:0032735) | 3.19028675 |
| 103 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.16697648 |
| 104 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.16538806 |
| 105 | positive regulation of interleukin-10 production (GO:0032733) | 3.15066370 |
| 106 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.14764942 |
| 107 | defense response to protozoan (GO:0042832) | 3.14416033 |
| 108 | positive regulation of interferon-beta production (GO:0032728) | 3.13378712 |
| 109 | positive regulation of acute inflammatory response (GO:0002675) | 3.13153726 |
| 110 | neutrophil chemotaxis (GO:0030593) | 3.12866163 |
| 111 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.12515272 |
| 112 | T cell migration (GO:0072678) | 3.11854450 |
| 113 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.11491017 |
| 114 | response to ATP (GO:0033198) | 3.10318362 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 3.09607749 |
| 116 | regulation of T cell cytokine production (GO:0002724) | 3.07078228 |
| 117 | natural killer cell activation involved in immune response (GO:0002323) | 3.06685108 |
| 118 | regulation of immunoglobulin secretion (GO:0051023) | 3.06138514 |
| 119 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.05640969 |
| 120 | neutrophil mediated immunity (GO:0002446) | 3.05423130 |
| 121 | neutrophil migration (GO:1990266) | 3.04327042 |
| 122 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.03694938 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 3.03606201 |
| 124 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.02847782 |
| 125 | germinal center formation (GO:0002467) | 3.00502735 |
| 126 | positive regulation of interleukin-17 production (GO:0032740) | 2.99927403 |
| 127 | regulation of interleukin-6 production (GO:0032675) | 2.97898275 |
| 128 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.97017723 |
| 129 | cellular response to biotic stimulus (GO:0071216) | 2.96863992 |
| 130 | response to manganese ion (GO:0010042) | 2.96458515 |
| 131 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.95852954 |
| 132 | positive regulation of hair follicle development (GO:0051798) | 2.92553958 |
| 133 | positive regulation of hair cycle (GO:0042635) | 2.92553958 |
| 134 | activation of MAPKKK activity (GO:0000185) | 2.92270293 |
| 135 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89019224 |
| 136 | hemidesmosome assembly (GO:0031581) | 2.79580816 |
| 137 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.79383018 |
| 138 | regulation of T-helper cell differentiation (GO:0045622) | 2.79029400 |
| 139 | positive regulation of monooxygenase activity (GO:0032770) | 2.78156823 |
| 140 | negative regulation of cytokine secretion (GO:0050710) | 2.77895110 |
| 141 | regulation of integrin activation (GO:0033623) | 2.76720999 |
| 142 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.76529380 |
| 143 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.75518659 |
| 144 | positive regulation of protein export from nucleus (GO:0046827) | 2.73419412 |
| 145 | cellular response to ATP (GO:0071318) | 2.71200761 |
| 146 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.68013607 |
| 147 | decidualization (GO:0046697) | 2.65019528 |
| 148 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62054041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.85342252 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.71770163 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10495230 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80507390 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77443722 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69668768 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.62956968 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.61403207 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35725303 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.91341072 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75779921 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62790124 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60022202 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53942550 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45653818 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40197055 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26198573 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18537294 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12524920 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.6266296 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87289930 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84823665 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82424303 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71387018 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68598977 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67622366 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63017868 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58963293 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58408372 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54918265 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52100253 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50959989 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47052393 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44441851 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44210123 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38407448 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32488381 |
| 38 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.30631632 |
| 39 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30502239 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29124563 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26084529 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25686679 |
| 43 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21507982 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19328599 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19278328 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19068648 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19068648 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18494095 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18263992 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.15005421 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14084405 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12585103 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12281664 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10492893 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08973281 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08618067 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08542466 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08062948 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07810260 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03701027 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03558203 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01549223 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00817372 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99940107 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98475285 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97842583 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97500590 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97357970 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97254509 |
| 70 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97166494 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96897531 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95694223 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94658780 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94055604 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91219444 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91122843 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90680881 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87941317 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87702014 |
| 80 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86732146 |
| 81 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86517064 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86489083 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86467283 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86023220 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85488928 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85279148 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84524158 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84515454 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83743174 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83243050 |
| 91 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.82896097 |
| 92 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82622030 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82615785 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82294764 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80464464 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80455179 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79865485 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78487121 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77762587 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76974052 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73814051 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73280216 |
| 103 | MYB_26560356_Chip-Seq_TH1_Human | 0.70405282 |
| 104 | MAF_26560356_Chip-Seq_TH1_Human | 0.70266064 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67596217 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66186737 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64728788 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.64549158 |
| 109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.64181096 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63262394 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59650857 |
| 112 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.58880108 |
| 113 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.58880108 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58195396 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.57576005 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57304040 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.57273140 |
| 118 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.55413759 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55247967 |
| 120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54925933 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54194394 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.53626257 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.52112509 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.50665904 |
| 125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.49787790 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.48966926 |
| 127 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47806437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.20633259 |
| 2 | MP0009785_altered_susceptibility_to | 4.95162469 |
| 3 | MP0003724_increased_susceptibility_to | 4.29525970 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.02406801 |
| 5 | * MP0002148_abnormal_hypersensitivity_rea | 3.96668087 |
| 6 | MP0003436_decreased_susceptibility_to | 3.94841137 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.52428425 |
| 8 | * MP0002419_abnormal_innate_immunity | 3.43204613 |
| 9 | MP0005025_abnormal_response_to | 3.30917623 |
| 10 | MP0003303_peritoneal_inflammation | 3.25159195 |
| 11 | MP0009764_decreased_sensitivity_to | 2.81225171 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.63518816 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.55510561 |
| 14 | * MP0002723_abnormal_immune_serum | 2.47921201 |
| 15 | MP0005671_abnormal_response_to | 2.26679171 |
| 16 | MP0004947_skin_inflammation | 2.26337056 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.24050991 |
| 18 | MP0001800_abnormal_humoral_immune | 2.21752208 |
| 19 | MP0005387_immune_system_phenotype | 2.17630988 |
| 20 | MP0001790_abnormal_immune_system | 2.17630988 |
| 21 | MP0004510_myositis | 2.15406922 |
| 22 | MP0001853_heart_inflammation | 2.15087510 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.13743705 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.12139066 |
| 25 | MP0003075_altered_response_to | 2.12006285 |
| 26 | MP0009278_abnormal_bone_marrow | 2.08637536 |
| 27 | MP0005058_abnormal_lysosome_morphology | 2.05741924 |
| 28 | * MP0001819_abnormal_immune_cell | 2.05425952 |
| 29 | MP0000685_abnormal_immune_system | 2.04569194 |
| 30 | MP0001845_abnormal_inflammatory_respons | 2.02548511 |
| 31 | * MP0002420_abnormal_adaptive_immunity | 2.01590300 |
| 32 | MP0003448_altered_tumor_morphology | 1.96134196 |
| 33 | * MP0008469_abnormal_protein_level | 1.85317928 |
| 34 | MP0005166_decreased_susceptibility_to | 1.77691707 |
| 35 | MP0003195_calcinosis | 1.75078259 |
| 36 | MP0002405_respiratory_system_inflammati | 1.74942181 |
| 37 | MP0003690_abnormal_glial_cell | 1.74763593 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.65084798 |
| 39 | MP0000343_altered_response_to | 1.64484274 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.62505432 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.58333522 |
| 42 | MP0005164_abnormal_response_to | 1.57036401 |
| 43 | MP0003828_pulmonary_edema | 1.56035278 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.51842200 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.50063881 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.38735936 |
| 47 | MP0003186_abnormal_redox_activity | 1.37297536 |
| 48 | * MP0002006_tumorigenesis | 1.36826079 |
| 49 | MP0005023_abnormal_wound_healing | 1.36186323 |
| 50 | MP0000716_abnormal_immune_system | 1.33469647 |
| 51 | MP0001216_abnormal_epidermal_layer | 1.32948209 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.30220849 |
| 53 | MP0003646_muscle_fatigue | 1.30022848 |
| 54 | MP0005451_abnormal_body_composition | 1.26194229 |
| 55 | MP0006054_spinal_hemorrhage | 1.25008459 |
| 56 | MP0008004_abnormal_stomach_pH | 1.24528186 |
| 57 | MP0000604_amyloidosis | 1.23560950 |
| 58 | * MP0000858_altered_metastatic_potential | 1.23436335 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.21475061 |
| 60 | MP0005310_abnormal_salivary_gland | 1.20564116 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.19345803 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.18635695 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.18196154 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.16593678 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.16593678 |
| 66 | MP0002398_abnormal_bone_marrow | 1.11388371 |
| 67 | MP0009763_increased_sensitivity_to | 1.10717995 |
| 68 | MP0005390_skeleton_phenotype | 1.05786619 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.04943637 |
| 70 | MP0000579_abnormal_nail_morphology | 1.04067472 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.03893358 |
| 72 | MP0002429_abnormal_blood_cell | 1.01657674 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.00141591 |
| 74 | MP0004883_abnormal_blood_vessel | 0.99641007 |
| 75 | MP0001849_ear_inflammation | 0.96280375 |
| 76 | MP0002254_reproductive_system_inflammat | 0.95669994 |
| 77 | MP0003950_abnormal_plasma_membrane | 0.93384801 |
| 78 | MP0000920_abnormal_myelination | 0.92863807 |
| 79 | MP0002933_joint_inflammation | 0.91466226 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.88080197 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.87873901 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.86390275 |
| 83 | MP0008260_abnormal_autophagy | 0.84184720 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.82853455 |
| 85 | MP0002722_abnormal_immune_system | 0.82635046 |
| 86 | MP0000249_abnormal_blood_vessel | 0.81676895 |
| 87 | MP0001851_eye_inflammation | 0.80830317 |
| 88 | MP0002060_abnormal_skin_morphology | 0.80610756 |
| 89 | MP0000750_abnormal_muscle_regeneration | 0.79791201 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.79691306 |
| 91 | MP0002796_impaired_skin_barrier | 0.77597958 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.75306512 |
| 93 | MP0004484_altered_response_of | 0.73920450 |
| 94 | MP0010678_abnormal_skin_adnexa | 0.73705840 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.73037373 |
| 96 | MP0009840_abnormal_foam_cell | 0.72174825 |
| 97 | MP0001663_abnormal_digestive_system | 0.71693012 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.69557735 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.69095677 |
| 100 | MP0008874_decreased_physiological_sensi | 0.68602932 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.68263898 |
| 102 | MP0003795_abnormal_bone_structure | 0.67794628 |
| 103 | MP0005266_abnormal_metabolism | 0.66826984 |
| 104 | * MP0005535_abnormal_body_temperature | 0.64051918 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.63500023 |
| 106 | MP0000371_diluted_coat_color | 0.63327001 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.60094179 |
| 108 | MP0001191_abnormal_skin_condition | 0.59363842 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.58980387 |
| 110 | MP0008873_increased_physiological_sensi | 0.58768627 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.57497795 |
| 112 | MP0004858_abnormal_nervous_system | 0.51975963 |
| 113 | MP0004130_abnormal_muscle_cell | 0.49270273 |
| 114 | MP0005165_increased_susceptibility_to | 0.47090627 |
| 115 | MP0003045_fibrosis | 0.46691596 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.46603763 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.45518378 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.44457599 |
| 119 | MP0002090_abnormal_vision | 0.43615963 |
| 120 | MP0005171_absent_coat_pigmentation | 0.41046549 |
| 121 | MP0005174_abnormal_tail_pigmentation | 0.40755218 |
| 122 | MP0003136_yellow_coat_color | 0.39377063 |
| 123 | MP0003091_abnormal_cell_migration | 0.39237928 |
| 124 | MP0002168_other_aberrant_phenotype | 0.38191790 |
| 125 | MP0000609_abnormal_liver_physiology | 0.37104081 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.37010292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.24625662 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.82394888 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.47326279 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.28199968 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.39238878 |
| 6 | Stomatitis (HP:0010280) | 6.19947131 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.24262873 |
| 8 | Optic neuritis (HP:0100653) | 5.05848051 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 5.05848051 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.01947867 |
| 11 | Orchitis (HP:0100796) | 4.86462711 |
| 12 | Gingivitis (HP:0000230) | 4.70155327 |
| 13 | Myositis (HP:0100614) | 4.42372342 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.41750576 |
| 15 | Recurrent skin infections (HP:0001581) | 4.39599544 |
| 16 | Amyloidosis (HP:0011034) | 4.24650733 |
| 17 | Obstructive lung disease (HP:0006536) | 4.09022545 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09022545 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 4.07212877 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 4.01384580 |
| 21 | Onycholysis (HP:0001806) | 3.87515935 |
| 22 | Vasculitis (HP:0002633) | 3.86007130 |
| 23 | Milia (HP:0001056) | 3.76766914 |
| 24 | Plantar hyperkeratosis (HP:0007556) | 3.59859554 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.59458214 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52028598 |
| 27 | Abnormality of nail color (HP:0100643) | 3.47289750 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.42058258 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.42020039 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.40649577 |
| 31 | Episodic fever (HP:0001954) | 3.39832541 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 3.38601389 |
| 33 | Axonal loss (HP:0003447) | 3.28937295 |
| 34 | Prostate neoplasm (HP:0100787) | 3.25175796 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.23441667 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.17502788 |
| 37 | Periodontitis (HP:0000704) | 3.16051522 |
| 38 | Alopecia of scalp (HP:0002293) | 3.11614967 |
| 39 | Increased IgM level (HP:0003496) | 3.06518754 |
| 40 | Recurrent viral infections (HP:0004429) | 3.04911795 |
| 41 | Loss of speech (HP:0002371) | 3.04259245 |
| 42 | Urticaria (HP:0001025) | 2.96668728 |
| 43 | Thick nail (HP:0001805) | 2.93113308 |
| 44 | Cellulitis (HP:0100658) | 2.92749043 |
| 45 | Pustule (HP:0200039) | 2.90060865 |
| 46 | Fragile nails (HP:0001808) | 2.89102521 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.87774021 |
| 48 | Nail dystrophy (HP:0008404) | 2.85209183 |
| 49 | Tetraparesis (HP:0002273) | 2.85166957 |
| 50 | Poor head control (HP:0002421) | 2.84986224 |
| 51 | Palmoplantar hyperkeratosis (HP:0000972) | 2.80831521 |
| 52 | Atrophic scars (HP:0001075) | 2.80389306 |
| 53 | Disinhibition (HP:0000734) | 2.80165111 |
| 54 | Glomerulonephritis (HP:0000099) | 2.76547925 |
| 55 | Abnormality of the pericardium (HP:0001697) | 2.75591692 |
| 56 | Meningitis (HP:0001287) | 2.71836457 |
| 57 | Nausea (HP:0002018) | 2.71100578 |
| 58 | Progressive sensorineural hearing impairment (HP:0000408) | 2.68991157 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67941278 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67941278 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.67879491 |
| 62 | Petechiae (HP:0000967) | 2.64291064 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.62447087 |
| 64 | Oral leukoplakia (HP:0002745) | 2.61202812 |
| 65 | Palmar hyperkeratosis (HP:0010765) | 2.59759490 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.58752060 |
| 67 | Purpura (HP:0000979) | 2.55384524 |
| 68 | Premature loss of primary teeth (HP:0006323) | 2.54120963 |
| 69 | Abnormal blistering of the skin (HP:0008066) | 2.53320280 |
| 70 | Arterial thrombosis (HP:0004420) | 2.49891977 |
| 71 | Parakeratosis (HP:0001036) | 2.49069793 |
| 72 | Ridged nail (HP:0001807) | 2.42607390 |
| 73 | Polyneuropathy (HP:0001271) | 2.41154971 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.40860088 |
| 75 | Apathy (HP:0000741) | 2.39621327 |
| 76 | Joint swelling (HP:0001386) | 2.39168003 |
| 77 | Nephritis (HP:0000123) | 2.38986548 |
| 78 | Hemoptysis (HP:0002105) | 2.36463759 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36034825 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36034825 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36034825 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33325208 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.32406481 |
| 84 | Osteomyelitis (HP:0002754) | 2.29414532 |
| 85 | Diminished motivation (HP:0000745) | 2.29380081 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.28708342 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.28516947 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.27365095 |
| 89 | Leukocytosis (HP:0001974) | 2.26374836 |
| 90 | Joint hemorrhage (HP:0005261) | 2.25058158 |
| 91 | Porencephaly (HP:0002132) | 2.24906727 |
| 92 | Myocardial infarction (HP:0001658) | 2.24310621 |
| 93 | Agnosia (HP:0010524) | 2.22696352 |
| 94 | Gingival bleeding (HP:0000225) | 2.17423797 |
| 95 | Fused cervical vertebrae (HP:0002949) | 2.16007036 |
| 96 | Bone pain (HP:0002653) | 2.15430517 |
| 97 | Abnormality of placental membranes (HP:0011409) | 2.14920202 |
| 98 | Amniotic constriction ring (HP:0009775) | 2.14920202 |
| 99 | Lower limb hyperreflexia (HP:0002395) | 2.13447552 |
| 100 | Arthralgia (HP:0002829) | 2.12301452 |
| 101 | Esophageal neoplasm (HP:0100751) | 2.11954057 |
| 102 | Neoplasm of head and neck (HP:0012288) | 2.11954057 |
| 103 | Malnutrition (HP:0004395) | 2.10637702 |
| 104 | Xerostomia (HP:0000217) | 2.08044943 |
| 105 | Gastrointestinal stroma tumor (HP:0100723) | 2.07841793 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 2.07078636 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 2.07013566 |
| 108 | Thin bony cortex (HP:0002753) | 2.04424555 |
| 109 | Gangrene (HP:0100758) | 2.03325254 |
| 110 | Restrictive lung disease (HP:0002091) | 2.02602013 |
| 111 | Increased IgE level (HP:0003212) | 1.99717329 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.98892962 |
| 113 | Mutism (HP:0002300) | 1.98093663 |
| 114 | Nuclear cataract (HP:0100018) | 1.97740941 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97601288 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97601288 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97601288 |
| 118 | Progressive visual loss (HP:0000529) | 1.96319026 |
| 119 | Sepsis (HP:0100806) | 1.96096653 |
| 120 | Anorexia (HP:0002039) | 1.93946771 |
| 121 | Pruritus (HP:0000989) | 1.92587954 |
| 122 | Hypoplasia of dental enamel (HP:0006297) | 1.92476345 |
| 123 | Pathologic fracture (HP:0002756) | 1.90979497 |
| 124 | Metaphyseal irregularity (HP:0003025) | 1.90191534 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89744809 |
| 126 | Pigmentary retinal degeneration (HP:0001146) | 1.87728122 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.87056724 |
| 128 | Peritonitis (HP:0002586) | 1.86710603 |
| 129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85629710 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83541993 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.83541993 |
| 132 | Progressive neurologic deterioration (HP:0002344) | 1.83140668 |
| 133 | Progressive hearing impairment (HP:0001730) | 1.82783218 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.82748252 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 1.82263773 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.82050554 |
| 137 | Aplasia cutis congenita (HP:0001057) | 1.81554076 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.78517127 |
| 139 | Hematochezia (HP:0002573) | 1.76710143 |
| 140 | Vertebral compression fractures (HP:0002953) | 1.74127783 |
| 141 | Lymphopenia (HP:0001888) | 1.71539234 |
| 142 | Increased serum ferritin (HP:0003281) | 1.71047528 |
| 143 | Skin ulcer (HP:0200042) | 1.70818304 |
| 144 | Abnormality of T cell number (HP:0011839) | 1.69918024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.77135641 |
| 2 | BLK | 5.13098312 |
| 3 | PBK | 4.94472631 |
| 4 | MAP3K14 | 4.84394964 |
| 5 | TBK1 | 3.62561337 |
| 6 | IRAK3 | 3.39270890 |
| 7 | TXK | 3.23165719 |
| 8 | IRAK4 | 2.87063928 |
| 9 | IKBKB | 2.49381197 |
| 10 | IKBKE | 2.28690454 |
| 11 | TAOK2 | 2.18763380 |
| 12 | MAP3K13 | 2.10071640 |
| 13 | MAP4K1 | 2.01128304 |
| 14 | JAK3 | 1.94830373 |
| 15 | TYK2 | 1.80959818 |
| 16 | MAP3K3 | 1.79354266 |
| 17 | LATS2 | 1.77634473 |
| 18 | BMPR2 | 1.72327752 |
| 19 | MAP3K9 | 1.70180338 |
| 20 | FGR | 1.65288888 |
| 21 | STK24 | 1.65065914 |
| 22 | PIM2 | 1.64848083 |
| 23 | CHUK | 1.62534232 |
| 24 | TAOK1 | 1.62080590 |
| 25 | CSK | 1.59787495 |
| 26 | MAP3K12 | 1.57425170 |
| 27 | BMX | 1.44044353 |
| 28 | JAK1 | 1.43117106 |
| 29 | MST1R | 1.41523612 |
| 30 | PRPF4B | 1.39071139 |
| 31 | TAOK3 | 1.29624455 |
| 32 | ABL2 | 1.25626019 |
| 33 | ERBB4 | 1.24275406 |
| 34 | PDGFRA | 1.23896166 |
| 35 | LYN | 1.22363865 |
| 36 | CDC42BPA | 1.21128829 |
| 37 | MST4 | 1.19489883 |
| 38 | YES1 | 1.19486208 |
| 39 | ERN1 | 1.18638840 |
| 40 | ZAP70 | 1.16654131 |
| 41 | MATK | 1.14924415 |
| 42 | MARK3 | 1.14253944 |
| 43 | IRAK2 | 1.13511592 |
| 44 | SYK | 1.08269238 |
| 45 | EIF2AK2 | 1.05704249 |
| 46 | RPS6KA4 | 1.03939435 |
| 47 | TYRO3 | 1.02954467 |
| 48 | IRAK1 | 1.02908460 |
| 49 | MAP3K5 | 1.02740425 |
| 50 | PIM1 | 1.01691990 |
| 51 | KIT | 1.00973452 |
| 52 | ADRBK2 | 1.00119794 |
| 53 | HCK | 0.99220126 |
| 54 | JAK2 | 0.95338685 |
| 55 | GRK7 | 0.94875686 |
| 56 | LCK | 0.86127065 |
| 57 | PRKCD | 0.82599372 |
| 58 | CSF1R | 0.77607837 |
| 59 | NME2 | 0.75899312 |
| 60 | ARAF | 0.73985494 |
| 61 | STK4 | 0.73442121 |
| 62 | PAK4 | 0.73341202 |
| 63 | NEK9 | 0.71230332 |
| 64 | BTK | 0.69421443 |
| 65 | EPHB1 | 0.66432431 |
| 66 | MAP3K11 | 0.65989305 |
| 67 | ABL1 | 0.63867202 |
| 68 | STK10 | 0.61704670 |
| 69 | ERBB3 | 0.59878752 |
| 70 | EGFR | 0.52448091 |
| 71 | RIPK1 | 0.50993197 |
| 72 | TESK1 | 0.50424818 |
| 73 | TEC | 0.47690757 |
| 74 | PRKCQ | 0.45315787 |
| 75 | MUSK | 0.45177971 |
| 76 | KSR1 | 0.44926448 |
| 77 | EPHA3 | 0.43809705 |
| 78 | MAP3K1 | 0.43293021 |
| 79 | BMPR1B | 0.42835137 |
| 80 | PDPK1 | 0.42337076 |
| 81 | FYN | 0.42056547 |
| 82 | MAP3K10 | 0.41898996 |
| 83 | PDK2 | 0.39837584 |
| 84 | KSR2 | 0.37387188 |
| 85 | DAPK3 | 0.36742506 |
| 86 | BRAF | 0.36372938 |
| 87 | PDK1 | 0.35946905 |
| 88 | FES | 0.35060806 |
| 89 | TTN | 0.34737794 |
| 90 | EPHA2 | 0.34213613 |
| 91 | FGFR3 | 0.33814308 |
| 92 | SIK3 | 0.33650354 |
| 93 | ADRBK1 | 0.33622693 |
| 94 | STK3 | 0.32524056 |
| 95 | TGFBR1 | 0.32072008 |
| 96 | LRRK2 | 0.30759005 |
| 97 | SIK1 | 0.30396123 |
| 98 | NLK | 0.30230913 |
| 99 | TGFBR2 | 0.29430176 |
| 100 | STK38L | 0.28445635 |
| 101 | PKN1 | 0.28424578 |
| 102 | IGF1R | 0.27334215 |
| 103 | CDK6 | 0.26693022 |
| 104 | EPHB2 | 0.26626743 |
| 105 | FGFR4 | 0.26257156 |
| 106 | DDR2 | 0.25753001 |
| 107 | TRPM7 | 0.24008042 |
| 108 | MET | 0.23385957 |
| 109 | PRKCZ | 0.23042370 |
| 110 | PDGFRB | 0.22600445 |
| 111 | INSR | 0.21924749 |
| 112 | MOS | 0.21360406 |
| 113 | MAPK4 | 0.20352158 |
| 114 | DYRK3 | 0.20204113 |
| 115 | MAPKAPK2 | 0.20165598 |
| 116 | CLK1 | 0.19815612 |
| 117 | ACVR1B | 0.19634022 |
| 118 | MAP3K8 | 0.19299150 |
| 119 | PIK3CG | 0.18764161 |
| 120 | RPS6KL1 | 0.17417608 |
| 121 | RPS6KC1 | 0.17417608 |
| 122 | SGK3 | 0.17043251 |
| 123 | GSK3A | 0.16554479 |
| 124 | PRKCE | 0.16464178 |
| 125 | PLK2 | 0.15598632 |
| 126 | ITK | 0.14958921 |
| 127 | MAP2K3 | 0.13854810 |
| 128 | MAP2K6 | 0.11097288 |
| 129 | RPS6KA1 | 0.10699412 |
| 130 | MAPK7 | 0.10568975 |
| 131 | SRC | 0.10538971 |
| 132 | PRKCH | 0.10161488 |
| 133 | RPS6KA6 | 0.08540424 |
| 134 | RAF1 | 0.07779208 |
| 135 | PTK2 | 0.07368796 |
| 136 | HIPK2 | 0.07363044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.17735712 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 3.79916814 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.37857711 |
| 4 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.34329888 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.26600256 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.23300486 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11907020 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 3.01442332 |
| 9 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.91268502 |
| 10 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.85676536 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85649236 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.64803800 |
| 13 | * Pertussis_Homo sapiens_hsa05133 | 2.51509956 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.44901125 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.38334932 |
| 16 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38148495 |
| 17 | * Salmonella infection_Homo sapiens_hsa05132 | 2.37868520 |
| 18 | * Tuberculosis_Homo sapiens_hsa05152 | 2.33810865 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.25868430 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.16381210 |
| 21 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99100980 |
| 22 | * Measles_Homo sapiens_hsa05162 | 1.84766160 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.69304258 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64081161 |
| 25 | * Influenza A_Homo sapiens_hsa05164 | 1.63828083 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.58494805 |
| 27 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54752658 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48484662 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41627926 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.39017201 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35462102 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34363705 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.27970483 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.21142751 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16949679 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16598463 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13953460 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11754326 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04426806 |
| 40 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91978400 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91514917 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91042892 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.90327270 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.87796402 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.84238447 |
| 46 | * Prion diseases_Homo sapiens_hsa05020 | 0.82768979 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.82215054 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77004748 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74963978 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70356684 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67851009 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62339850 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59448201 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56909044 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55561360 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54699953 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.53176028 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52632784 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52189363 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46372352 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45087191 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44142816 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43151826 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43047834 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42757607 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40577731 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40195929 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39849647 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37709597 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37014779 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32544350 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29876933 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.29618761 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29189728 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28994767 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28252657 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27871845 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27296351 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26698605 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26569674 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25237827 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24565556 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23548561 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20712871 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18598974 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18460962 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17675550 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17572478 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.17011782 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16496085 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15840376 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.14580719 |
| 93 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13614756 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.13152736 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12801464 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12166770 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.10435783 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.10418827 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07916310 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07448727 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.07222056 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06894877 |
| 103 | Proteasome_Homo sapiens_hsa03050 | 0.06768271 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.05680777 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05351511 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05349777 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04419429 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.02995085 |
| 109 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.02430275 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.00277129 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | -0.0259409 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0191582 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0159097 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | -0.0093946 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | -0.0092044 |

